Literature DB >> 32317224

North American Prodrome Longitudinal Study (NAPLS 3): Methods and baseline description.

Jean Addington1, Lu Liu2, Kali Brummitt2, Carrie E Bearden3, Kristin S Cadenhead4, Barbara A Cornblatt5, Matcheri Keshavan6, Daniel H Mathalon7, Thomas H McGlashan8, Diana O Perkins9, Larry J Seidman6, William Stone6, Ming T Tsuang10, Elaine F Walker11, Scott W Woods8, Tyrone D Cannon12.   

Abstract

The North American Prodrome Longitudinal Study (NAPLS) is a consortium of nine programs focusing on youth at clinical high risk (CHR) for psychosis. Funded by the National Institute of Mental Health (NIMH), the sites are located at Emory University, Harvard University, University of Calgary, University of California at Los Angeles, at San Diego, and at San Francisco, University of North Carolina Chapel Hill, Yale University, and Zucker Hillside Hospital. There have been two previous endeavors completed by this consortium, known as NAPLS-1 and NAPLS-2. This paper first offers an overview of the methodology of the third phase of the NAPLS consortium, the second five-year prospective study NAPLS-3, which aims to determine mechanisms of the development of psychosis. In addition, we report on the ascertainment and demographics of the 710 CHR participants in NAPLS-3.
Copyright © 2020 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Clinical high risk; Methodology; Psychosis; Schizophrenia

Mesh:

Year:  2020        PMID: 32317224      PMCID: PMC7572535          DOI: 10.1016/j.schres.2020.04.010

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.662


  10 in total

1.  Sleep Disturbance in Individuals at Clinical High Risk for Psychosis.

Authors:  Nina Zaks; Tjasa Velikonja; Muhammad A Parvaz; Jamie Zinberg; Monica Done; Daniel H Mathalon; Jean Addington; Kristin Cadenhead; Tyrone Cannon; Barbara Cornblatt; Thomas McGlashan; Diana Perkins; William S Stone; Ming Tsuang; Elaine Walker; Scott W Woods; Matcheri S Keshavan; Daniel J Buysse; Eva Velthorst; Carrie E Bearden
Journal:  Schizophr Bull       Date:  2022-01-21       Impact factor: 7.348

2.  Longitudinal impact of trauma in the North American Prodrome Longitudinal Study-3.

Authors:  Megan S Farris; Amy Braun; Lu Liu; Carrie E Bearden; Kristin S Cadenhead; Barbara A Cornblatt; Matcheri Keshavan; Daniel H Mathalon; Thomas H McGlashan; Diana O Perkins; William S Stone; Ming T Tsuang; Elaine F Walker; Scott W Woods; Tyrone D Cannon; Jean Addington
Journal:  Early Interv Psychiatry       Date:  2022-02-13       Impact factor: 2.721

3.  Research Trends in Individuals at High Risk for Psychosis: A Bibliometric Analysis.

Authors:  Tae Young Lee; Soo Sang Lee; Byoung-Gyu Gong; Jun Soo Kwon
Journal:  Front Psychiatry       Date:  2022-04-29       Impact factor: 5.435

4.  Visual cortical plasticity and the risk for psychosis: An interim analysis of the North American Prodrome Longitudinal Study.

Authors:  Michael S Jacob; Brian J Roach; Holly K Hamilton; Ricardo E Carrión; Aysenil Belger; Erica Duncan; Jason Johannesen; Matcheri Keshavan; Sandra Loo; Margaret Niznikiewicz; Jean Addington; Carrie E Bearden; Kristin S Cadenhead; Tyrone D Cannon; Barbara A Cornblatt; Thomas H McGlashan; Diana O Perkins; William Stone; Ming Tsuang; Elaine F Walker; Scott W Woods; Daniel H Mathalon
Journal:  Schizophr Res       Date:  2021-03-02       Impact factor: 4.939

5.  Family-focused therapy for individuals at high clinical risk for psychosis: A confirmatory efficacy trial.

Authors:  David J Miklowitz; Jean M Addington; Mary P O'Brien; Danielle M Denenny; Marc J Weintraub; Jamie L Zinberg; Daniel H Mathalon; Barbara A Cornblatt; Michelle S Friedman-Yakoobian; William S Stone; Kristin S Cadenhead; Scott W Woods; Catherine A Sugar; Tyrone D Cannon; Carrie E Bearden
Journal:  Early Interv Psychiatry       Date:  2021-08-23       Impact factor: 2.721

6.  Individualized Prediction of Prodromal Symptom Remission for Youth at Clinical High Risk for Psychosis.

Authors:  Michelle A Worthington; Jean Addington; Carrie E Bearden; Kristin S Cadenhead; Barbara A Cornblatt; Matcheri Keshavan; Daniel H Mathalon; Thomas H McGlashan; Diana O Perkins; William S Stone; Ming T Tsuang; Elaine F Walker; Scott W Woods; Tyrone D Cannon
Journal:  Schizophr Bull       Date:  2022-03-01       Impact factor: 7.348

7.  Counterpoint. Early intervention for psychosis risk syndromes: Minimizing risk and maximizing benefit.

Authors:  Scott W Woods; Carrie E Bearden; Fred W Sabb; William S Stone; John Torous; Barbara A Cornblatt; Diana O Perkins; Kristin S Cadenhead; Jean Addington; Albert R Powers; Daniel H Mathalon; Monica E Calkins; Daniel H Wolf; Cheryl M Corcoran; Leslie E Horton; Vijay A Mittal; Jason Schiffman; Lauren M Ellman; Gregory P Strauss; Daniel Mamah; Jimmy Choi; Godfrey D Pearlson; Jai L Shah; Paolo Fusar-Poli; Celso Arango; Jesus Perez; Nikolaos Koutsouleris; Jijun Wang; Jun Soo Kwon; Barbara C Walsh; Thomas H McGlashan; Steven E Hyman; Raquel E Gur; Tyrone D Cannon; John M Kane; Alan Anticevic
Journal:  Schizophr Res       Date:  2020-05-10       Impact factor: 4.662

8.  The Relationship Between Grey Matter Volume and Clinical and Functional Outcomes in People at Clinical High Risk for Psychosis.

Authors:  Stefania Tognin; Anja Richter; Matthew J Kempton; Gemma Modinos; Mathilde Antoniades; Matilda Azis; Paul Allen; Matthijs G Bossong; Jesus Perez; Christos Pantelis; Barnaby Nelson; Paul Amminger; Anita Riecher-Rössler; Neus Barrantes-Vidal; Marie-Odile Krebs; Birte Glenthøj; Stephan Ruhrmann; Gabriele Sachs; Bart P F Rutten; Lieuwe de Haan; Mark van der Gaag; Lucia R Valmaggia; Philip McGuire
Journal:  Schizophr Bull Open       Date:  2022-06-20

9.  A computational lens on menopause-associated psychosis.

Authors:  Victoria L Fisher; Liara S Ortiz; Albert R Powers
Journal:  Front Psychiatry       Date:  2022-08-03       Impact factor: 5.435

10.  Neurocognitive Functioning in Individuals at Clinical High Risk for Psychosis: A Systematic Review and Meta-analysis.

Authors:  Ana Catalan; Gonzalo Salazar de Pablo; Claudia Aymerich; Stefano Damiani; Veronica Sordi; Joaquim Radua; Dominic Oliver; Philip McGuire; Anthony J Giuliano; William S Stone; Paolo Fusar-Poli
Journal:  JAMA Psychiatry       Date:  2021-06-16       Impact factor: 25.911

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.